Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMMED A SIDDIQUI

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1831171347
CMS profile
219263
Location
ELIZABETHTOWN, KY

General Payments · PY2018–2024

$3,656.28

  • Reported across 235 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$663.76

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $663.76 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $269.51 15
ABBVIE INC. $183.41 12
GlaxoSmithKline, LLC. $56.15 3
Sandoz Inc. $43.67 2
NOVARTIS PHARMACEUTICALS CORPORATION $36.77 2
PFIZER INC. $20.54 1
Aurinia Pharma U.S., Inc. $18.59 1
ANI Pharmaceuticals, Inc. $17.99 1
Genentech USA, Inc. $17.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $398.42 26
PY2019 $453.44 36
PY2020 $399.63 28
PY2021 $452.77 31
PY2022 $571.27 34
PY2023 $716.99 42
PY2024 $663.76 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $9.50 01/25/2024 Food and Beverage Undisputed 01/23/2026 1106098269 CMS
ABBVIE INC. $19.55 02/08/2024 Food and Beverage Undisputed 01/23/2026 1106098271 CMS
ABBVIE INC. $16.76 03/21/2024 Food and Beverage Undisputed 01/23/2026 1106098273 CMS
ABBVIE INC. $22.18 03/29/2024 Food and Beverage Undisputed 01/23/2026 1106098275 CMS
ABBVIE INC. $18.56 04/12/2024 Food and Beverage Undisputed 01/23/2026 1106098277 CMS
ABBVIE INC. $4.97 04/12/2024 Food and Beverage Undisputed 01/23/2026 1106098279 CMS
ABBVIE INC. $19.72 05/03/2024 Food and Beverage Undisputed 01/23/2026 1106098281 CMS
ABBVIE INC. $14.36 06/11/2024 Food and Beverage Undisputed 01/23/2026 1106098283 CMS
ABBVIE INC. $5.73 08/13/2024 Food and Beverage Undisputed 01/23/2026 1106098285 CMS
ABBVIE INC. $22.04 10/10/2024 Food and Beverage Undisputed 01/23/2026 1106098287 CMS
ABBVIE INC. $6.52 12/05/2024 Food and Beverage Undisputed 01/23/2026 1106098289 CMS
ABBVIE INC. $23.52 12/13/2024 Food and Beverage Undisputed 01/23/2026 1106098291 CMS
Amgen Inc. $24.70 01/18/2024 Food and Beverage Undisputed 01/23/2026 1116124079 CMS
Amgen Inc. $6.33 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116124133 CMS
Amgen Inc. $20.90 02/07/2024 Food and Beverage Undisputed 01/23/2026 1116124159 CMS
Amgen Inc. $10.74 02/29/2024 Food and Beverage Undisputed 01/23/2026 1116124139 CMS
Amgen Inc. $23.74 03/07/2024 Food and Beverage Undisputed 01/23/2026 1117684062 CMS
Amgen Inc. $16.28 03/14/2024 Food and Beverage Undisputed 01/23/2026 1116124085 CMS
Amgen Inc. $26.48 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116124092 CMS
Amgen Inc. $23.21 05/09/2024 Food and Beverage Undisputed 01/23/2026 1116124098 CMS
Amgen Inc. $6.86 05/14/2024 Food and Beverage Undisputed 01/23/2026 1116124106 CMS
Amgen Inc. $20.79 06/20/2024 Food and Beverage Undisputed 01/23/2026 1116124145 CMS
Amgen Inc. $16.43 07/18/2024 Food and Beverage Undisputed 01/23/2026 1116124151 CMS
Amgen Inc. $26.95 07/25/2024 Food and Beverage Undisputed 01/23/2026 1116124112 CMS
Amgen Inc. $9.61 09/19/2024 Food and Beverage Undisputed 01/23/2026 1116124119 CMS
Amgen Inc. $19.73 10/03/2024 Food and Beverage Undisputed 01/23/2026 1116124071 CMS
Amgen Inc. $16.76 11/14/2024 Food and Beverage Undisputed 01/23/2026 1116124125 CMS
ANI Pharmaceuticals, Inc. $17.99 07/12/2024 Food and Beverage Undisputed 01/23/2026 1091171874 CMS
Aurinia Pharma U.S., Inc. $18.59 05/22/2024 Food and Beverage Undisputed 01/23/2026 1150692210 CMS
Genentech USA, Inc. $17.13 08/16/2024 Food and Beverage Undisputed 01/23/2026 1133075120 CMS
GlaxoSmithKline, LLC. $21.43 02/01/2024 Food and Beverage Undisputed 01/23/2026 1115962474 CMS
GlaxoSmithKline, LLC. $16.88 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116023062 CMS
GlaxoSmithKline, LLC. $17.84 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116703952 CMS
Novartis Pharmaceuticals Corporation $21.77 05/31/2024 Food and Beverage Undisputed 01/23/2026 1087227459 CMS
Novartis Pharmaceuticals Corporation $15.00 08/29/2024 Food and Beverage Undisputed 01/23/2026 1087227473 CMS
PFIZER INC. $20.54 09/13/2024 Food and Beverage Undisputed 01/23/2026 1131982863 CMS
Sandoz Inc. $21.68 01/05/2024 Food and Beverage Undisputed 01/23/2026 1089371596 CMS
Sandoz Inc. $21.99 04/25/2024 Food and Beverage Undisputed 01/23/2026 1089371654 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.